From GlobeNewswire: 2024-09-15 08:45:00

1. A recent study has shown a significant improvement in radiographic progression-free survival, meeting its primary endpoint. The Overall Response Rate was 38.1% compared to 12.0% in the switch arm, with a 9.3% Complete Response rate.

2. Patients in the study also experienced a statistically significant improvement in the time to reduction of health-related quality of life, as measured by the Functional Assessment of Cancer Therapy—Prostate (FACT-P) tool.

3. The Interim Overall Survival Crossover Adjusted Hazard Ratio was [specific ratio not provided], indicating positive outcomes for patients involved in the study.



Read more at GlobeNewswire: Lantheus Presents Results from the Primary Analysis of